Free Trial

FibroBiologics (FBLG) Institutional Ownership

FibroBiologics logo
$1.75 -0.16 (-8.38%)
As of 01/17/2025 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for FibroBiologics (NASDAQ:FBLG)

Number of
Institutional Buyers
(last 12 months)
18
Total
Institutional Inflows
(last 12 months)
$10.25M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$176.26K
Get FBLG Insider Trade Alerts

Want to know when executives and insiders are buying or selling FibroBiologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

FBLG Institutional Buying and Selling by Quarter

FibroBiologics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC39,958$123K0.0%+363.2%0.115%
11/16/2024Geode Capital Management LLC599,760$1.85M0.0%+90.0%1.706%
11/15/2024Barclays PLC39,958$123K0.0%+363.2%0.114%
11/15/2024Jane Street Group LLC11,852$37K0.0%N/A0.034%
11/15/2024State Street Corp475,837$1.47M0.0%+26.5%1.353%
11/13/2024The Manufacturers Life Insurance Company10,264$32K0.0%N/A0.029%
11/12/2024Charles Schwab Investment Management Inc.69,732$215K0.0%+5.2%0.198%
10/22/2024Symphony Financial Ltd. Co.23,772$76K0.0%N/A0.067%
8/14/2024Marshall Wace LLP16,702$83K0.0%-67.9%0.047%
8/12/2024Mercer Global Advisors Inc. ADV10,272$51K0.0%N/A0.029%
8/6/2024Fund Evaluation Group LLC1,055,105$5.27M0.3%N/A3.001%
8/6/2024Cahaba Wealth Management Inc.14,702$73K0.0%N/A0.041%
8/1/2024Rhumbline Advisers23,057$115K0.0%N/A0.065%
7/31/2024Cascade Financial Partners LLC315,055$1.57M0.2%N/A0.882%
7/31/2024Concurrent Investment Advisors LLC35,283$176K0.0%N/A0.099%
7/26/2024Bank of New York Mellon Corp68,558$342K0.0%N/A0.192%
7/23/2024 RMR Wealth Builders37,360$186K0.0%N/A0.105%
7/18/2024 Saxon Interests Inc.21,214$106K0.1%N/A0.059%
7/17/2024 ERn Financial LLC31,819$159K0.0%N/A0.089%
7/15/2024Transform Wealth LLC133,890$668K0.1%N/A0.375%
(Data available from 1/1/2016 forward)

FBLG Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of FBLG shares?

During the previous two years, 19 institutional investors and hedge funds held shares of FibroBiologics. The most heavily invested institutionals were Fund Evaluation Group LLC ($5.27M), Geode Capital Management LLC ($1.85M), Cascade Financial Partners LLC ($1.57M), State Street Corp ($1.47M), Transform Wealth LLC ($668K), Bank of New York Mellon Corp ($342K), and Charles Schwab Investment Management Inc. ($215K).Learn more on FBLG's institutional investors.

Which institutional investors have been buying FibroBiologics stock?

Of the 18 institutional investors that purchased FibroBiologics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fund Evaluation Group LLC ($1.06M), Cascade Financial Partners LLC ($315.06K), Geode Capital Management LLC ($284.05K), Transform Wealth LLC ($133.89K), State Street Corp ($99.79K), Bank of New York Mellon Corp ($68.56K), and Barclays PLC ($62.66K).

How much institutional buying is happening at FibroBiologics?

Institutional investors have bought a total of 2,242,152 shares in the last 24 months. This purchase volume represents approximately $10.25M in transactions.

Which FibroBiologics major shareholders have been selling company stock?

The following institutional investors have sold FibroBiologics stock in the last 24 months: Marshall Wace LLP ($35.32K).

How much institutional selling is happening at FibroBiologics?

Institutional investors have sold a total of 35,323 shares in the last 24 months. This volume of shares sold represents approximately $176.26K in transactions.



This page (NASDAQ:FBLG) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners